Language selection

Search

Details for: BREVICON

Company: PFIZER CANADA ULC

DIN DIN name Active Ingredient(s) Strength Dosage Form Route of Administration
02187086BREVICON 0.5/35 TABLETS (21-DAY PACK)ETHINYL ESTRADIOL; NORETHINDRONE0.035 MG; 0.5 MGTABLETORAL
02187094BREVICON 0.5/35 TABLETS (28-DAY PACK)ETHINYL ESTRADIOL; NORETHINDRONE.035 MG; .5 MGTABLETORAL
02189054BREVICON 1/35 TABLETS (21-DAY PACK)NORETHINDRONE; ETHINYL ESTRADIOL1 MG; 0.035 MGTABLETORAL
02189062BREVICON 1/35 TABLETS (28-DAY PACK)NORETHINDRONE; ETHINYL ESTRADIOL1 MG; 0.035 MGTABLETORAL
Search Reported Side Effects Report a Side Effect

Summary Reports

Summary Safety Review - Hormone Replacement Therapy (Estrogenic and Progestogenic Agents) and Selective Estrogen Receptor Modulators (SERMs) - Assessing the Potential Risk of Ovarian Cancer
Summary Safety Review - Combined Hormonal Birth Control Products - Evaluating effectiveness when used by women who are obese
Summary Safety Review - Hormonal Birth Control Products (excluding Emergency Birth Control Products) - Assessing the Potential Risk of Suicidal Thoughts and Behaviours (suicidality)

Consumer Information

The Consumer Information is not yet available in the Drug and Health Product Register. Try searching on the active ingredient(s) to find other similar products.

Date modified: